Skip to content

The effect of rTMS on brain energy metabolism, cerebral blood flow and cognitive function in patients with Alzheimer's disease and its mechanism

The effect of rTMS on brain energy metabolism, cerebral blood flow and cognitive function in patients with Alzheimer's disease and its mechanism

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106199
Enrollment
Unknown
Registered
2025-07-21
Start date
2025-07-21
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimers disease

Interventions

The rTMS treatment group:rTMS treatment
Sham stimulation group:Sound and environment of rTMS treatment

Sponsors

Zigong Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria for Alzheimer's disease or mild cognitive impairment; 2. Age >=60 years old 3 Right handed; (Not left-handed) 4. Good general condition and no other diseases that could affect the study (such as serious medical or psychiatric diseases; Traumatic brain injury; No severe alcohol dependence and drug abuse, etc.); 5. Ignoring hearing impairment; 6. Native speaker of Chinese; 7. Agree to do TCD examination, without contraindications to TCD examination; 8. Sign informed consent.

Exclusion criteria

Exclusion criteria: Other neurological diseases that can cause cognitive decline other than suspected early Alzheimer's disease: such as Parkinson's disease, vascular dementia, Huntington's disease, positive-pressure hydrocephalus, brain tumors, progressive supranuclear palsy, epilepsy, subdural hematoma, multiple sclerosis or brain trauma causing neurological damage and other brain structural abnormalities; Other systemic diseases that can cause cognitive decline: Hashimoto's encephalopathy, metabolic encephalopathy, general paresis, anemia, hepatic encephalopathy, renal encephalopathy, etc. Mental disorders: major depression, bipolar disorder, schizophrenia, etc.

Design outcomes

Primary

MeasureTime frame
Cerebral blood flow (TCD test);Cognitive scale (MMSE, Moca, etc.);Serum UCH-L1;

Countries

China

Contacts

Public ContactMin Zhang

Zigong Mental Health Center

1511923196@qq.com+86 182 8453 1831

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026